Clinical Trial Update: Feasibility Study of a Transdermal Continuous Glucose Monitoring (CGM) System in Diabetic Patients [NA]

View source ↗

Summary

A feasibility study evaluating a transdermal continuous glucose monitoring (CGM) system in diabetic patients has completed. The sponsor is EyeSense GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: EyeSense GmbH | Conditions: Diabetes | NA | Status: COMPLETED